Latest Asx Company Filings News

Light & Wonder, Inc. reported a steady 2% revenue rise in Q1 2025, marking its 16th consecutive quarter of growth, alongside margin expansion and a $166 million share buyback. The company is on track to close its strategic $850 million acquisition of Grover Gaming’s charitable business.

Pro Medicus Limited’s U.S. subsidiary, Visage Imaging, has landed a significant five-year, A$20 million contract to implement its cloud-based Visage 7 imaging platform at University of Iowa Health Care, marking a major step in cloud adoption for healthcare IT.

Brightstar Resources reports compelling gold assay results from Sandstone and Laverton, confirming resource growth potential and accelerating drilling plans across key Western Australian projects.

NTAW Holdings has terminated its Australian Dunlop tyre distribution agreements, entering new contracts with Sumitomo Rubber Industries and Goodyear entities, while continuing Dunlop distribution in New Zealand. The move marks a strategic pivot as NTAW aims to grow other business units and reduce costs.

Minerals 260 Limited has secured an option agreement for 26 tenements near its Bullabulling Gold Project, expanding its regional footprint to approximately 570 square kilometres and reinforcing its exploration ambitions in Western Australia’s Eastern Goldfields.

Strickland Metals kicks off its 2025 drilling campaign with strong high-grade intercepts at the Rogozna Project, reinforcing the commercial potential of its 5.3Moz AuEq Shanac Deposit.

ARN Media Limited’s 2025 AGM update highlights robust financial health, a strategic $40 million transformation program, and strong digital audio momentum despite a modest revenue dip year-to-date.

Capral Limited reported steady 2024 financial results with solid profitability despite softer residential markets, while announcing board changes and continuing its share buy-back program.

ARN Media reports resilient 2024 financials driven by digital growth and Cody Outdoor contracts, launching a major cost-cutting transformation to sharpen its competitive edge.

LTR Pharma has partnered with Strategic Drug Solutions to co-develop OROFLOW®, a novel intranasal spray aimed at providing fast symptom relief for Oesophageal Motility Disorders, tapping into a growing $4.5 billion global market.

Memphasys Limited has successfully trialed its RoXsta™ Mega Cell High-Throughput Assay, capable of processing 96 antioxidant tests in under an hour, promising a leap forward in rapid, cost-effective oxidative stress analysis.

Guzman y Gomez has unveiled an ambitious expansion and margin improvement plan at the 2025 Macquarie Australia Conference, reaffirming its FY25 guidance and spotlighting strong franchise growth and operational excellence.